Latest period
$340.16M
YoY change
+10.1%
5Y CAGR
+6.7%
Peak year (2025)
$310.88M
Latest annual
$310.88M
Dividends Paid history chart for ResMed (RMD) from 1993 to 2025
Latest: $310.88M
Dividends Paid growth chart for ResMed (RMD) from 1993 to 2025
Latest: +10.1%
Dividends Paid history table for ResMed (RMD) from 1993 to 2025
| 2025 | $310.88M | +10.1% | +$28.56M | ||
| 2024 | $282.32M | +9.3% | +$24.04M | ||
| 2023 | $258.28M | +5.3% | +$12.94M | ||
| 2022 | $245.34M | +8.2% | +$18.63M | ||
| 2021 | $226.71M | +0.7% | +$1.62M | ||
| 2020 | $225.09M | +6.3% | +$13.38M | ||
| 2019 | $211.71M | +6.1% | +$12.21M | ||
| 2018 | $199.50M | +7.1% | +$13.15M | ||
| 2017 | $186.35M | +10.8% | +$18.22M | ||
| 2016 | $168.13M | +6.9% | +$10.87M | ||
| 2015 | $157.26M | +11.1% | +$15.74M | ||
| 2014 | $141.52M | +45.6% | +$44.31M | ||
| 2013 | $97.20M | — | +$97.20M | ||
| 2012 | $0.00 | — | $0.00 | ||
| 2011 | $0.00 | — | $0.00 | ||
| 2010 | $0.00 | — | $0.00 | ||
| 2009 | $0.00 | — | $0.00 | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | -100.0% | −$200.00K | ||
| 1994 | $200.00K | — | +$200.00K | ||
| 1993 | $0.00 | — | — |
- 2025$310.88M+10.1%
- 2024$282.32M+9.3%
- 2023$258.28M+5.3%
- 2022$245.34M+8.2%
- 2021$226.71M+0.7%
- 2020$225.09M+6.3%
- 2019$211.71M+6.1%
- 2018$199.50M+7.1%
- 2017$186.35M+10.8%
- 2016$168.13M+6.9%
- 2015$157.26M+11.1%
- 2014$141.52M+45.6%
- 2013$97.20M—
- 2012$0.00—
- 2011$0.00—
- 2010$0.00—
- 2009$0.00—
- 2008$0.00—
- 2007$0.00—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00-100.0%
- 1994$200.00K—
- 1993$0.00—
Dividends Paid values are taken from ResMed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Dividends Paid at ResMed (RMD)
Dividends Paid for ResMed (RMD): headline value $340.16M · YoY +10.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ResMed (RMD) most recent annual dividends paid stands at $310.88M (2025) – grew 10.1% year-over-year.
Through 2020–2025 (5 years), ResMed dividends paid delivered a +6.7% annualised rate; sustaining 13 straight years of year-over-year growth.
Across the available history, dividends paid reached its high of $310.88M in 2025 and its low of $0.00 in 1993.
ResMed Dividends Paid by Year
ResMed Dividends Paid 2025: $310.88M
ResMed dividends paid in 2025 was $310.88M, grew 10.1% from 2024. This figure represents the highest annual value in the available history.
ResMed Dividends Paid 2024: $282.32M
2024's dividends paid for ResMed came in at $282.32M, grew 9.3% from 2023.
ResMed Dividends Paid 2023: $258.28M
ResMed posted dividends paid of $258.28M in 2023, grew 5.3% from 2022.
ResMed Dividends Paid 2022: $245.34M
In 2022, ResMed reported dividends paid of $245.34M, grew 8.2% from 2021.
ResMed Dividends Paid 2021: $226.71M
ResMed dividends paid in 2021 was $226.71M.
See more financial history for ResMed (RMD).
Sector peers by Dividends Paid
Healthcare peers of ResMed (RMD), ranked by their latest dividends paid
| $12.38B | |
| $11.66B | |
| $8.18B | |
| $8.07B | |
| $7.92B | |
| $5.38B | |
| $5.12B | |
| $5.08B |
- $12.38B
- $11.66B
- $8.18B
- $8.07B
- $7.92B
- $5.38B
- $5.12B
- $5.08B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation